Koers GlobeImmune Inc Other OTC
Aandelen
US37957B1008
Biotechnologie & Medisch Onderzoek
Omzet 2014 | 5,97 mln. 5,55 mln. | Omzet 2015 | 6,46 mln. 6,01 mln. | Marktkapitalisatie | 22,26 mln. 20,71 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -16 mln. -14,89 mln. | Nettowinst (verlies) 2015 | -2 mln. -1,86 mln. | EV/omzet 2014 | 4,5 x |
Nettoliquiditeiten 2014 | 16,81 mln. 15,65 mln. | Nettoliquiditeiten 2015 | 9,9 mln. 9,21 mln. | EV/omzet 2015 | 1,91 x |
K/w-verhouding 2014 |
-0,94
x | K/w-verhouding 2015 |
-8,04
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Augustine Lawlor
BRD | Director/Board Member | 67 | 01-06-03 |
Ehud Geller
BRD | Director/Board Member | 77 | - |
Charles C. Kim
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,72% | 125 mld. | |
+14,19% | 108 mld. | |
-4,93% | 24,21 mld. | |
+0,73% | 22,78 mld. | |
-10,67% | 17,96 mld. | |
-41,74% | 16,43 mld. | |
-13,31% | 16,37 mld. | |
+2,44% | 13,58 mld. | |
+27,89% | 11,66 mld. |